DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Sign in and take the values quiz to see how this bill lines up with what you've said.
The Uterine Cancer Study Act of 2024 directs the Secretary of Health and Human Services, in coordination with the FDA and National Institutes of Health, to conduct a study examining the relationship between chemical hair straighteners and uterine cancer, with particular focus on incidence among women of color. The study must review existing findings, analyze results by product type (dyes, bleach, highlights, perms), and determine whether the FDA should require additional safety testing for hair straightening products. The Secretary must submit a methodology within 45 days, commence the study within 180 days, and complete a final report within 2 years of enactment.
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
Sign in to see how your representatives voted on this bill.